Track enVVeno Medical Corporation Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

enVVeno Medical Corporation Common Stock NVNO · Stock Open enVVeno Medical Corporation Common Stock in new tab

6.17 USD
EPS
-23.27
P/B
0.27
ROE
-67.11
Beta
1.38
Loading chart...
Key Metrics
Earnings dateMarch 4, 2027
EPS-23.27
Book Value24.32
Price to Book0.27
Debt/Equity2.41
% Insiders8.081%
Estimates
Forward P/E-1.05
Forward EPS-6.22

DCF valuation

Model fair value for enVVeno Medical Corporation Common Stock (NVNO)
Result
Sign in to run the valuation for NVNO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

enVVeno Medical Corporation Common Stock Logo enVVeno Medical Corporation Common Stock Analysis (NVNO)

United States Health Care Official Website Stock

Is enVVeno Medical Corporation Common Stock a good investment? enVVeno Medical Corporation Common Stock (NVNO) is currently trading at 6.17 USD.

Earnings Schedule: enVVeno Medical Corporation Common Stock is expected to release its next earnings report on March 4, 2027. The market consensus estimate for Forward EPS is -6.22.

Investor FAQ

Does enVVeno Medical Corporation Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is enVVeno Medical Corporation Common Stock?

enVVeno Medical Corporation Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 4, 2027. The company currently has a trailing EPS of -23.27.

Company Profile

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Exchange Ticker
NMS (United States) NVNO
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Nov. 30, 2020 1:25
Jan. 20, 2026 0.03
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion